SynthesisDiabetes, obesity & metabolism2023

Larger effect size in composite kidney outcomes than in major cardiovascular events associated with sodium-glucose cotransporter-2 (SGLT2) inhibitors compared with glucagon-like peptide-1 receptor agonists (GLP-1RAs): A pooled analysis of type 2 diabetes trials.

Alhassane Diallo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.